Abstract
Over the last two decades, transcatheter devices have been developed to repair or replace diseased mitral valves (MV). Transcatheter mitral valve repair (TMVr) devices have been proven to be efficient and safe, but many anatomical structures are not compatible with these technologies. The most significant advantage of transcatheter mitral valve replacement (TMVR) over transcatheter repair is the greater and more reliable reduction in mitral regurgitation. However, there are also potential disadvantages. This review introduces the newest TMVr and TMVR devices and presents clinical trial data to identify current challenges and directions for future research.
Original language | English |
---|---|
Article number | 3377 |
Journal | Journal of Clinical Medicine |
Volume | 11 |
Issue number | 12 |
ISSN | 2077-0383 |
DOIs | |
Publication status | Published - 2022 |
Bibliographical note
Publisher Copyright:© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords
- access
- approach
- endovascular
- mitral insufficiency
- mitral regurgitation
- percutaneous
- transcatheter mitral valve repair
- transcatheter mitral valve replacement
- transcatheter technology
- transluminal